Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial Geurts et al
Background: Low back pain (LBP) is one of the most common spine diseases and represents the most fre...
BACKGROUND: Minimal interventional procedures are frequently applied in patients with mechanical low...
BACKGROUND: Back pain is one of the most expensive health complaints. Comparing the economic aspects...
Background: Low back pain (LBP) is a common health problem and a substantial part of LBP is presumed...
Study DesignProspective clinical study of intradiscal methylene blue injection for the treatment of ...
A study published in PAIN in 2010 showed remarkable effects of intradiscal methylene blue (MB) injec...
Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluatio
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
INTRODUCTION: Discogenic pain is the cause of pain in 26%-40% of patients with for low back pain. Co...
INTRODUCTION: Discogenic pain is the cause of pain in 26%-40% of patients with for low back pain. Co...
Low back pain (LBP) is one of the most common spine diseases and represents the most frequent cause ...
International audienceThe benefit of an intradiscal injection of corticosteroids for low back pain w...
Background: Low back pain (LBP) is one of the most common spine diseases and represents the most fre...
BACKGROUND: Minimal interventional procedures are frequently applied in patients with mechanical low...
BACKGROUND: Back pain is one of the most expensive health complaints. Comparing the economic aspects...
Background: Low back pain (LBP) is a common health problem and a substantial part of LBP is presumed...
Study DesignProspective clinical study of intradiscal methylene blue injection for the treatment of ...
A study published in PAIN in 2010 showed remarkable effects of intradiscal methylene blue (MB) injec...
Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluatio
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
INTRODUCTION: Discogenic pain is the cause of pain in 26%-40% of patients with for low back pain. Co...
INTRODUCTION: Discogenic pain is the cause of pain in 26%-40% of patients with for low back pain. Co...
Low back pain (LBP) is one of the most common spine diseases and represents the most frequent cause ...
International audienceThe benefit of an intradiscal injection of corticosteroids for low back pain w...
Background: Low back pain (LBP) is one of the most common spine diseases and represents the most fre...
BACKGROUND: Minimal interventional procedures are frequently applied in patients with mechanical low...
BACKGROUND: Back pain is one of the most expensive health complaints. Comparing the economic aspects...